Gilead Sciences | GILD - Biaya Penjualan

Harga Saham
130.47
Perubahan Harian
-3.17 -2.37%
Bulanan
-5.63%
Tahunan
26.46%
Q2 Perkiraan
134.61




Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.55B 757M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
ALKERMES USD 46.21M 5.38M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Coherus Biosciences USD 4.04M 324K 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Incyte USD 121.18M 22.18M 2025-12
J&J USD 8.07B 103M 2026-03
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 3.67B 621M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12